November 18, 2026 - News

Hone Health Secures $228M, Enters Peptides and PMOS Care

White coat.
Telehealth consult
Hone Health

Hone Health is taking a bigger step into healthcare.

What’s happening: The diagnostic-led longevity platform announced a $28M equity investment led by Jay-Z’s MarcyPen Capital Partners and $200M in growth financing from General Catalyst’s Customer Value Fund (CVF).

Adding to $33M raised last year, Hone will now enter PMOS, metabolic health, and autoimmune care while exploring clinical trials.

White glove. Hone combines diagnostics, AI interpretation, and physician-led programs for 200K patients. Connecting longitudinal insight to precision care, it’s adding diagnostics like full-body MRI, DEXA, heart CTs, and microbiome tests alongside peptide and GLP-1 prescriptions.

Entering concierge medicine, it’s launching an advanced membership analyzing 1.6K+ biomarkers.

White coat. Expanding beyond its roots in men’s health, CEO Saad Alam says the company is building a research platform to accelerate health outcomes, including for tough-to-treat hormonal conditions. Bought in, goop founder and Hone investor Gwyneth Paltrow believes it can take the once-niche wellness conversation mainstream.

Looking ahead: As consumer-led healthcare grows crowded, Hone is stacking specialties and pursuing science-supported outcomes to stand out.

Ryan Deer
Ryan Deer
Strategic intelligence for the future of health.

We break down how fitness, wellness, and healthcare are converging — and what it means for business, culture, and capital.

No thanks.